Hautarztpraxis Kock
- Address
- Oyther Str. 24, 49377 Vechta, Germany
Hautarztpraxis Kock - Dermatological Research Center
Hautarztpraxis Kock is a specialized dermatology practice dedicated to advancing the treatment of inflammatory skin conditions through rigorous clinical research. The center focuses on evaluating novel topical formulations and comparing them with established therapies to optimize patient outcomes in common dermatological disorders.
- Atopic dermatitis treatment development and corticosteroid formulation studies
- Rosacea therapeutic trials focusing on papulopustular manifestations
- Comparative efficacy studies of topical anti-inflammatory agents
The research team at Hautarztpraxis Kock conducts controlled clinical trials examining both methylprednisolone aceponate formulations for mild to moderate atopic dermatitis and ivermectin-based therapies for papulopustular rosacea. Their expertise includes comprehensive safety and efficacy assessments, utilizing vehicle-controlled designs to establish therapeutic superiority and guide evidence-based prescribing practices in dermatology.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Dermapharm AG2active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Dermapharm AG2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hautarztpraxis Kock
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparative Efficacy and Safety of Ivermectin 10 mg/g Cream Versus Vehicle in Patients with Papulopustular Rosacea: A Randomized, Double-Blind Study | Dermapharm AG | Phase III | Recruiting | Dec 2024 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ivermectin | 1 | Unknown | 2024-12-02 | 2024-12-02 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.